Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:August 18, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:August 18, 2017Completed
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:February 19, 2019Recruiting
Condition(s):Osteonecrosis; Acute Lymphoblastic LeukemiaLast Updated:April 15, 2010Unknown status
Condition(s):Acute Leukemia (Category)Last Updated:December 13, 2016Unknown status
Condition(s):Leukemia; Acute Lymphoblastic LeukemiaLast Updated:December 3, 2020Completed
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:May 20, 2014Completed
Condition(s):Acute Lymphoid LeukemiaLast Updated:January 4, 2022Unknown status
Condition(s):Recurrent Adult Acute Lymphoblastic Leukemia; Refractory Adult Acute Lymphoblastic LeukemiaLast Updated:December 15, 2016Withdrawn
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:February 8, 2017Completed
Condition(s):ph+ Acute Lymphoblastic LeukemiaLast Updated:February 24, 2016Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.